| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000017506 |
| Receipt No. | R000020295 |
| Official scientific title of the study | A clinical study on the potential therapeutic effects of intramuscular injection of G-CSF on the athlete patients with muscle strain injury |
| Date of disclosure of the study information | 2015/05/12 |
| Last modified on | 2016/06/11 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A clinical study on the potential therapeutic effects of intramuscular injection of G-CSF on the athlete patients with muscle strain injury | |
| Title of the study (Brief title) | A clinical study on G-CSF and muscle injury | |
| Region |
|
|
| Condition | |||
| Condition | muscle strain injury | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To elucidate the potential therapeutic effects of intramuscular injection of G-CSF on the athlete patients with muscle strain injury |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Muscle regeneration and recovery of muscle strengthe |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intramuscular injection of G-CSF.
Standard treatment for muscle injury. |
|
| Interventions/Control_2 | Standard treatment for muscle injury. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Within 3 days after injury.
Consent on the study. |
|||
| Key exclusion criteria | Potentially pregnatn patients. | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Masaya Nakamura |
| Organization | Keio University School of Medicine |
| Division name | Dept. of Orthopaedic Surgery |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| masa@keio.jp | |
| Public contact | |
| Name of contact person | Kengo Harato |
| Organization | Keio University School of Medicine |
| Division name | Dept. of Orthopedic Surgery |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-5363-3812 |
| Homepage URL | |
| kharatoh@yahoo.co.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | NA |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kitasato University Kitasato Institute Hospital, Edogawa hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020295 |